Alan Larsen, MD
Plastic Surgery · Atlanta, GANPI 1871633362
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (44.9%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. AbbVie accounts for 63.8% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2021 at $24,114 and has fallen 97.6% since, to $581 in 2025. Among plastic surgery clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 257 payments — averaging $185.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$30K
- Mentor Worldwide LLC$15K
- Musculoskeletal Transplant Foundation Inc.$2K
- Sientra, Inc.$269
- Galderma Laboratories, L.p.$53
- Medline Industries LP$42
- plus $55 from 3 others
Across 374 payments — averaging $849.20 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Mentor Worldwide LLC$288K
- Medical Device Business Services, Inc.$28K
- Sientra, Inc.$2K
What the payments were for
- Consulting fees$14,38630%
- Speaking & faculty fees$21,39745%
- Travel & lodging$4,53010%
- Food & beverage$6,29813%
- Education$170%
- Gifts$1,0272%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 210 | $30,424 |
| Mentor Worldwide LLC | 34 | $15,270 |
| Musculoskeletal Transplant Foundation Inc. | 4 | $1,542 |
| Sientra, Inc. | 1 | $269 |
| Galderma Laboratories, L.p. | 3 | $53 |
| Medline Industries LP | 2 | $42 |
| Trevena, Inc. | 1 | $22 |
| Pacira Pharmaceuticals Incorporated | 1 | $18 |
| TEI Biosciences Inc | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$47,654 in reported general payments places this provider in the 95th percentile of 163 plastic surgery providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 38 | $273 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 34 | $267 |
| Promethazine Hcl | 31 | $74 |
| Diazepam | 28 | $65 |
Paid to pharmacies, not to this prescriber.
Other plastic surgery in Atlanta
- Albert LoskenAtlanta$436K
- Jonathan NguyenAtlanta$364K
- Brian MaloneyAtlanta$224K
- Farzad NahaiAtlanta$129K
- Sara NeimanisAtlanta$51K
- Foad NahaiAtlanta$29K
- Bahair GhaziAtlanta$17K
- Drew MetcalfeAtlanta$14K
- John SymbasAtlanta$12K
- Alexandra HartAtlanta$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.